https://www.selleckchem.com/pr....oducts/alkbh5-inhibi
fect on reducing postoperative complications. Therefore, it is worthy of clinical popularization and application. To investigate the effect of dose-painted intensity-modulated radiotherapy (DP-IMRT) combined with chemotherapy on stage IIIB cervical cancer. A total of 107 stage IIIB cervical cancer patients were treated with DP-IMRT combined with chemotherapy. The planning target volume (PTV) was divided into regions with different prescribed absorbed doses (so-called PTV-subvolume [PTVsv]) PTVsv (the part of the PTV that over
Like
Comment
Share
